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The AP-2a transcription factor is required for multiple aspects of vertebrate development and mice lacking the AP-2a gene (tcfap2a) die
at birth from severe defects affecting the head and trunk. Several of the defects associated with the tcfap2a-null mutation affect neural crest
cell (NCC) derivatives including the craniofacial skeleton, cranial ganglia, and heart outflow tract. Consequently, there is considerable
interest in the role of AP-2a in neural crest cell function in development and evolution. In addition, the expression of the AP-2a gene is
utilized as a marker for premigratory and migratory neural crest cells in many vertebrate species. Here, we have specifically addressed how
the presence of AP-2a in neural crest cells affects development by creating a conditional (floxed) version of tcfap2a which has subsequently
been intercrossed with mice expressing Cre recombinase under the control of Wnt1 cis-regulatory sequences. Neural crest-specific disruption
of tcfap2a results in frequent perinatal lethality associated with neural tube closure defects and cleft secondary palate. A small but significant
fraction of mutant mice can survive into adulthood, but have retarded craniofacial growth, abnormal middle ear development, and defects in
pigmentation. The phenotypes obtained confirm that AP-2a directs important aspects of neural crest cell function. At the same time, we did
not observe several neurocristopathies affecting the head and heart that might be expected based on the phenotype of the AP-2a-null mouse.
These results have important implications for the evolution and function of the AP-2 gene family in both the neural crest and the vertebrate
embryo.
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The existence, design, and diversification of the verte-
brate body plan are intimately linked with the appearance
and function of the neural crest cell (NCC) during evolution
(Hall, 1999; Le Douarin and Kalcheim, 1999). The neural
crest is induced at the margins of the neural plate as a
population of pluripotent stem cells derived from the em-
bryonic ectoderm (Knecht and Bronner-Fraser, 2002). These
cells then undergo an epithelial–mesenchymal transition
and enter a migratory phase following defined pathways
throughout the embryo. NCCs arising at different positions0012-1606/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
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1 These authors contributed equally to the project.along the anterior–posterior axis of the embryo give rise to
different sets of cell and tissue types (Chai et al., 2000; Jiang
et al., 2000, 2002; Le Douarin and Kalcheim, 1999; Trainor
and Krumlauf, 2001). Much of the vertebrate craniofacial
skeleton and connective tissue is derived from NCCs
originating in the fore-, mid-, and hindbrain regions. Such
cranial NCCs also give rise to neurons and glia of the cranial
ganglia and melanocytes in the head. In more cervical
regions, the cardiac NCCs contribute to the thyroid, para-
thyroid, thymus, and heart outflow tract. NCCs originating
in the trunk are required for formation of the adrenal gland,
the dorsal root ganglia, the enteric nervous system, and
melanocytes.
Recently, the tissue interactions and molecular mecha-
nisms required for NCC induction have come under intense
scrutiny in several model organisms, including mouse,
chick, frog, and zebrafish (Knecht and Bronner-Fraser,
2002). The underlying processes appear similar in all of
these species, although there are some variations in detail
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Induction of the neural crest relies upon the apposition of
neural and non-neural ectoderm after gastrulation and
occurs at the junction between these two tissues. Several
secreted factors have been implicated in this induction
process. Initially, the interplay of bone morphogenetic
protein (BMP) agonists and antagonists is critical for
establishing the boundaries of the neural and non-neural
ectoderm. Next, members of the Wnt family, especially
wnt6 in chick, have a primary role in the induction of the
neural crest itself. Subsequently, a complex network of
growth factors, adhesion molecules, and transcription fac-
tors combine to coordinate the proliferation, migration, and
differentiation of the neural crest. Notably, transcription
factors of the Snail, Zic, Hox, Pax, Msx, Sox, Fox, bHLH,
and AP-2 gene families are frequently used as molecular
markers for NCC specification and many of these molecules
are also critical for NCC function (Knecht and Bronner-
Fraser, 2002; LaBonne and Bronner-Fraser, 1999; Trainor
and Krumlauf, 2001).
Here, we focus on the AP-2a gene that was first
postulated to be an important NCC transcription factor
based upon its expression pattern in the developing mouse
embryo (Mitchell et al., 1991). The AP-2a gene is the
archetypal member of the AP-2 family of ‘‘basic-helix-span-
helix’’ transcription factors which in mouse and human also
includes AP-2h, AP-2g, AP-2y, and AP-2q (Cheng et al.,
2002; Feng and Williams, 2003; Hilger-Eversheim et al.,
2000; Zhao et al., 2001). The family members share a
conserved C-terminal basic-helix-span-helix DNA binding
and dimerization domain, and a less conserved N-terminal
proline and aromatic-rich activation domain (Garcia et al.,
2000; Wankhade et al., 2000; Williams and Tjian, 1991a,b).
All the mammalian AP-2 proteins bind to a consensus DNA
sequence 5V-GCCNNNGGC-3V, although the preference of
the AP-2y protein for specific variations of this motif appear
slightly different from the other family members (McPher-
son and Weigel, 1999; Mohibullah et al., 1999; Zhao et al.,
2001). This gene family regulates important aspects of
vertebrate development (see below) and is linked with
tumor progression in both melanoma and breast cancer
(Bar-Eli, 2001; Gee et al., 1999; Turner et al., 1998; Zhang
et al., 2003).
During mouse embryogenesis, AP-2a expression occurs
in neural crest cells, and also in the ectoderm, the lens and
retina of the eye, the kidney, CNS, and limb buds (Brewer et
al., 2002; Feng and Williams, 2003; Hilger-Eversheim et al.,
2000; Mitchell et al., 1991; West-Mays et al., 1999). With
respect to the neural crest, expression is observed in
premigratory NCCs and is maintained in these cells as they
migrate throughout the trunk and cranial regions of the
embryo (Mitchell et al., 1991). Several tissues derived from
the neural crest continue to express AP-2a during their
growth and morphogenesis, including the frontonasal pro-
cess (FNP), branchial arches (BA), and peripheral nervous
system ganglia. Significant expression of AP-2 genes in theneural crest has also been reported in other vertebrate
species including chick, frog, axolotl, zebrafish, and lam-
prey (Furthauer et al., 1997; Luo et al., 2003; Meulemans
and Bronner-Fraser, 2002; Shen et al., 1997).
Evidence that the AP-2a gene was critical for the
developmental potential of the neural crest was originally
obtained from gene targeting studies performed in mouse.
Mice lacking both copies of the AP-2a gene die perinatally
from a combination of developmental defects affecting
formation of the neural tube, face, eye, body wall, cardio-
vascular system, and forelimbs (Brewer et al., 2002; Nottoli
et al., 1998; Schorle et al., 1996; West-Mays et al., 1999;
Zhang et al., 1996). A specific role for AP-2a in patterning
the neural crest was inferred from the dramatic changes
observed in the craniofacial skeleton in AP-2a-null mice
(Schorle et al., 1996; Zhang et al., 1996). The most striking
defects were in the mandible, where the two halves of the
jaw failed to fuse at the midline. The maxillary and
frontonasal prominences, structures which give rise to the
upper jaw and midface, were also affected to the extent that
they were not recognizable in the AP-2a-null mice. Fur-
thermore, in mouse chimeras, composed of wild-type and
AP-2a-null cells, these craniofacial structures were fre-
quently dysmorphic and clefted (Nottoli et al., 1998). In
addition, cranial ganglia, which are also cranial NCC
derivatives, were hypoplastic and prone to apoptosis in the
AP-2a-null mouse (Schorle et al., 1996; Zhang et al., 1996).
In more caudal regions of the AP-2a-null embryo, there
were also significant defects in the patterning of the heart
outflow tract, a further developmental process that relies
upon appropriate NCC function (Brewer et al., 2002).
Analysis of the other structures that are patterned by the
cardiac neural crest—the thymus, thyroid, and parathyroid—
has been more difficult in the AP-2a-null mouse due to
complications in morphogenesis resulting from the ventral
body wall closure defect. There were no obvious gross
morphological defects in trunk neural crest derivatives,
including the adrenal gland and the peripheral nervous
system. However, expression of the AP-2a target gene,
phenylethanolamine N-methyl transferase (PNMT), required
for epinephrine synthesis, was significantly reduced in the
adrenal gland in the AP-2a-null mice (Kennedy et al., 2002).
This latter finding indicates that AP-2a may regulate the
function of neural crest derivatives even if it does not effect
their morphogenesis. The developmental defects described
above are not caused by a failure of the NCC populations to
form and migrate appropriately because these cell processes
can be readily followed in the AP-2a knockout mice (Brewer
et al., 2002; Zhang et al., 1996). Instead, the data support the
hypothesis that the function of AP-2a becomes most impor-
tant when the NCCs reach their targets. Although similar
neural crest expression profiles have been described for the
related AP-2h and AP-2g proteins (Hilger-Eversheim et al.,
2000), defects in neural crest derivatives are specific for the
loss of AP-2a, and were not observed in AP-2h and AP-
2g-null mice (Auman et al., 2002; Moser et al., 1997).
Table 1
Oligonucleotides used for generation and genotype analysis of the various
alleles
Alflox1 5V-CCC TGG TTG CGC ACA GGT TAC AAG C-3V
Alflox4 5V-CCC AAA GTG CCT GGG CTG AAT TGA C-3V
Alflox202 5V-CAG AGT CAT TCT GAA CGC TAT AAC TTC G-3V
Alflp 5V-CCT GCC TTG GAA CCA TGA CCC TCA G-3V
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NCC formation and function has come from a study of
Xenopus and zebrafish developmental systems. In Xenopus,
morpholinos directed against AP-2a, or a dominant negative
version of AP-2a, can inhibit neural crest formation, indi-
cating that AP-2a may be required for this process (Luo et
al., 2003). In support of a central role for AP-2a in Xenopus
neural crest specification, ectopic expression of wild-type
AP-2a in the neural plate leads to the induction of neural
crest-specific genes and the concomitant repression of
neural markers. These data suggest a critical role for AP-
2a in the establishment and positioning of the premigratory
neural crest in Xenopus. However, the effect of altering AP-
2a levels on the later developmental events of NCC fate and
function have not been described to date in Xenopus. With
respect to zebrafish, two previously isolated mutant strains,
lockjaw (low) and montblanc (Neuhauss et al., 1996; Schil-
ling et al., 1996), have recently been shown to result from
null mutations in a gene homologous to mouse AP-2a
(Holzschuh et al., 2003; Knight et al., 2003). Interestingly,
the zebrafish AP-2a mutants are not as severely dysmorphic
as the AP-2a-null mice. The lockjaw mutants are charac-
terized by a reduction in the number of melanocytes, smaller
cranial ganglia, and loss of the enteric nervous system. The
craniofacial skeleton is also disrupted, particularly the
second pharyngeal arch, termed the hyoid arch, which in
mammals gives rise to one of the middle ear ossicles, the
stapes. The developmental abnormalities observed in the
zebrafish are consistent with a defect in NCC function.
Given the links between AP-2a and the neural crest in
vertebrates, we wished to ascertain if the function of AP-2a
in the mouse neural crest was intrinsic to this population of
cells. An alternative, but not mutually exclusive, possibility
was that the presence of AP-2a in other tissues is respon-
sible for patterning the neural crest-derived craniofacial
skeleton. To test these hypotheses, we generated a condi-
tional allele of the AP-2a gene and combined this mouse
strain with the Wnt1-Cre neural crest-specific transgenic
line (Danielian et al., 1998). Our results indicate that neural
crest-specific expression of AP-2a is critical for particular
aspects of craniofacial development, middle ear develop-
ment, and melanocyte formation. However, the data also
indicate that AP-2a expression in tissues other than the
neural crest must be required for the appropriate growth and
patterning of the neural crest itself. The significance of these
findings is discussed in terms of the function of AP-2 and
the evolution of the neural crest in vertebrates.
Alfscsq 5V-GAA TCT AGC TTG GAG GCT TAT GTC-3V
a 3VKO 5V-CGT GTG GCT GTT GGG GTT GTT GCT GAG
GTA C-3V
Alpha6/7F 5V-GAA AGG TGT AGG CAG AAG TTT GTC AGG GC-3V
AvrLoxP 5V-GTA TAA CTT CGT ATA GCA TAC ATT ATA CGA
AGT TAT AGC-3V
Cre1 5V-GCT GGT TAG CAC CGC AGG TGT AGA G-3V
Cre3 5V-CGC CAT CTT CCA GCA GGC GCA CC-3V
Flox5 5V-CCA TCA GAA GCT TAT CGA TAC CGT CG-3V
Kyko3333 5V-CCA CAT GAA GAA CTA ACA GGG AGG ATC C-3V
neo 3VKO 5V-AAC GCA CGG GTG TTG GGT CGT TTG TTC G-3VMaterials and methods
Generation of AP-2a floxed mice
The conditional AP-2a gene targeting vector was based
on a 6.4-kb fragment of 129/Sv mouse genomic DNA,
spanning from a HindIII site in the fourth intron of tcfap2ato a BamHI site approximately 750 nt downstream of the
stop codon in the seventh exon, which was obtained from a
previously characterized clone (Zhang et al., 1996). A
double-stranded oligonucleotide (AvrLoxP) containing a
loxP site, was added at an XmnI site located 75 nt upstream
of the fifth exon (see Table 1 for oligonucleotide sequen-
ces). The loxP-Frt-PGK-neo-Frt selection cassette was de-
rived from the plasmid pK11 (Meyers et al., 1998; gift of
Gail Martin) by restriction digestion with Ecl136II and
ApaI, followed by T4 repair of the ApaI site in the presence
of all four dNTPs (Sambrook and Russell, 2001). This
fragment was inserted into an Ecl136II site in the middle
of intron 6 and the correct orientation chosen by diagnostic
restriction digest and DNA sequencing. With the exception
of Ecl136II (MBI, Fermentas), all restriction endonucleases
were purchased from New England Biolabs. Subsequently,
two herpes simplex virus thymidine kinase expression
cassettes were placed downstream of the AP-2a sequences
to generate the conditional allele targeting vector (Fig. 1).
Following linearization with NotI, 25 Ag of the construct
was electroporated into CJ-7 ES cells by the Yale Gene
Targeting Core Facility. Neomycin-resistant colonies were
screened for the correct targeting event (the ‘‘Neoflox
allele,’’ Fig. 1) by PCR analysis using the enzyme rTth
DNA polymerase, XL (Perkin Elmer), according to the
manufacturer’s instructions, in a 25-Al reaction containing
0.8 mM magnesium acetate. Initially, screening was per-
formed for a homologous recombination event involving
genomic DNA and the 3Vregion of the targeting vector using
the primer pair Flox5 and Kyko3333 (Table 1). These
primers, respectively, occur within the neo gene and in
the genomic sequences downstream from the region of
homology (Fig. 1). The following program was used for
PCR amplification: 1 cycle of 94jC for 1V, followed by 36
cycles of 94jC for 1V, 68jC for 10V, and 1 cycle of 70jC for
20V. Six clones were identified based upon the presence of
the expected approximately 2-kb product in the PCR
reaction. Subsequently, the occurrence of a correct homol-
ogous recombination event involving the 5V end of the
Fig. 1. Derivation of a conditional allele of AP-2a and its Wnt1-Cre-mediated deletion in neural crest cell derivatives. (A) Diagrammatic representations from
top to bottom of the wild-type mouse AP-2a gene (top), targeting vector, recombinant locus (Neoflox), allele after removal of the neo gene with Flp
recombinase (Alflox), and Cre recombinase deleted allele (Floxdel). Exons 5, 6, and 7 (black boxes), restriction enzyme sites (B, BamHI; H, HindIII; S, SacI;
and Ecl136II; Xm, XmnI), loxP sites (grey triangles), and Frt sites (black triangles) are shown along with neomycin resistance (neo) and thymidine kinase (tk)
genes. The positions of the primer pairs used for PCR amplification are also shown (open arrows). (B) PCR analysis of Wnt1-Cre-mediated deletion of the
Alflox allele using primers Alflp, Alflox4, and Alfscsq. All mice contain the AP-2a:LacZ KI allele and this generates a 490-bp product with primers Alflox4
and Alfscsq. Note that the lacZ KI allele has a wild-type intron–exon structure in this region: the lacZ gene is placed within exon 7 coding sequences outside
the region analyzed by PCR. Alflox/KI and Floxdel/KI mice both have one conditional AP-2a allele, but only the Floxdel/KI mice also contain the Wnt1-Cre
transgene. The undeleted Alflox allele generates a band of 560 bp with primers Alflox4 and Alfscsq. The Floxdel allele produces a 185-bp band from primers
Alflp and Alfscsq. The deleted conditional allele is only detected in NCC-derived tissues in the presence of Wnt1-Cre. Ad, adrenal; Kdy, kidney; Thy, thyroid;
Spl, spleen.
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analysis using the primer pair Alflox1 and Alflox 202
(Table 1). These primers, respectively, occur within the
genomic sequences upstream from the region of homology
and in the sequences spanning the 5VloxP insertion site (Fig.
1). PCR amplification was performed using rTth DNA
polymerase, XL in the presence of 1.5 mM magnesium
acetate according to the following program: 1 cycle of 93jC
for 1V, followed by 36 cycles of 93jC for 1V, 65jC for 10V, and
1 cycle of 70jC for 20V. Properly targeted euploid ES clones
were identified and transfected with the h-actin Flpe ex-pression cassette (gift of Susan Dymecki) to delete the
PGK-neo gene cassette. Resulting clones were replica-
plated in the presence or absence of G418. The G418-
sensitive clones were screened for appropriate recombina-
tion (the ‘‘Alflox allele,’’ Fig. 1) by PCR using the primers
Alflox4 and Alfscsq. These primers generate a 490-bp band
for the wild-type allele, a >3 kb band for clones with an
intact FRT PGK-neo FRT cassette, and 560-bp for a Flp
deleted allele lacking the neo gene. Positive clones (Flp
deleted, neo sensitive) with the correct karyotype were
injected into C57BL/6 blastocysts. Resulting chimeric adult
S. Brewer et al. / Developmental Bmale animals were used to derive heterozygous AP-2a
Alflox offspring, and these were then bred to homozygosity
for the Alflox allele. The colony of Alflox mice were
initially expanded as heterozygotes by backcrossing with
outbred Black Swiss mice (Taconic), but have since been
maintained as a homozygous colony by sibling matings on
a mixed 129 Black Swiss background. Homozygous Alflox
mice are viable and fertile and do not have apparent defects.
Mating scheme and PCR genotyping
In the mating scheme we employed, only one floxed
allele needs to undergo recombination to generate tissue
null for the tcfap2a gene. In the first cross, mice heterozy-
gous for the AP-2a:LacZ KI allele, a null allele (Brewer et
al., 2002), were bred with Wnt1-Cre transgenic mice
(Danielian et al., 1998). Next, offspring that were hetero-
zygous for both the Cre gene and the AP-2a:LacZ KI allele
were then bred with homozygous Alflox mice. Theoreti-
cally, one quarter of the offspring from this mating should
contain the Wnt1-Cre transgene, one AP-2a:LacZ KI allele,
and one Alflox allele. DNA from embryo or adult tissue
samples was prepared using the DNeasy tissue kit (Qia-
gen). Genotyping for the floxed allele was performed by
PCR using the primers Alflp, Alflox4, and Alfscsq (Table
1, Fig. 1). These primers are able to distinguish a wild-type
allele (490 bp), the intact floxed allele (560 bp), and the
floxdel allele (185 bp). Mice carrying the Wnt1-Cre trans-
gene were identified using the primers Cre1 and Cre3 that
correspond to nts 1090–1114 and 1489–1511 of the Cre
recombinase gene, respectively. Genotyping protocols for
the AP-2a:LacZ KI allele have been described previously
(Brewer et al., 2002). Genotyping for the AP-2a-null allele
(Zhang et al., 1996) was performed by PCR using the
primers Alpha 3VKO, neo 3VKO, and Alpha 6/7 (Table 1).
These primers occur, respectively, in the seventh exon of
the AP-2a gene, at the 3Vend of the neo cassette, and in the
sixth intron. The genomic region corresponding to the latter
primer is missing from the AP-2a-null allele. PCR con-
ditions were 1 cycle of 95jC 1V20W, followed by 36 cycles
of 95jC 40W, 72jC 2V, and 1 cycle of 72jC for 10V. A 265-nt
product is generated from the AP-2a-null allele and a 500-
nt band from the wild-type allele.
Whole-mount b-galactosidase staining
Noon of the day of the copulatory plug was considered
0.5 days post coitum (dpc). Embryos taken at subsequent
time points were fixed in 0.25% glutaraldehyde in PBS for
30 min at 4jC and washed extensively in PBS. To assay for
h-galactosidase activity, whole embryos were incubated in
5-bromo-4-chloro-3-indolyl-h-D-galactopyranoside (X-gal).
Standard procedures were followed (Hogan et al., 1994)
and embryos were incubated in staining solution overnight
at 37jC, postfixed in 4% paraformaldehyde, and then
photographed.Whole-mount staining, analysis of tissue sections, and
skeletal staining
Whole-mount immunoperoxidase staining of mouse em-
bryos was performed essentially as described (Mark et al.,
1993) using the 2H3 anti-neurofilament monoclonal anti-
body. This antibody developed by Jessell, T.M and Dodd, J.
was obtained from the Developmental Studies Hybridoma
Bank developed under the auspices of the NICHD and
maintained by the Department of Biological Sciences,
University of Iowa, Iowa City, IA 52242. Whole-mount in
situ hybridizations using a Hoxa-2 RNA probe (Maconochie
et al., 1999) or a Sox10 RNA probe were performed as
described previously (Feng and Williams, 2003). The mouse
Sox10 probe was derived by PCR from E10.5 FVB mouse
head cDNA using the primers sox10F (5V-GCT CTG GAG
GCC AAG CCC TGA CTG AGC TGG-3V) and sox10R (5V-
GCT GAC AGA AGG CGA GAA GAA GGC TAG-3V).
The following program was used for PCR amplification: 1
cycle of 95jC for 3V, followed by 35 cycles of 95jC for 45W,
58jC for 45W, 72jC for 90W, and then 1 cycle of 72jC for
10V. The resulting 536-bp product, corresponding to nts
1918–2454 of XM_128139 (NCBI), was cloned into the
plasmid TOPO pCRII (Invitrogen). The Sox10 plasmid was
linearized with NotI and then transcribed with SP6 RNA
polymerase to generate an antisense RNA probe, or cut with
SpeI and transcribed with T7 RNA polymerase to obtain a
sense probe. For cryosectioning, embryos were fixed in 4%
PFA overnight and embedded in OCT compound, then
sectioned at 20 uM and stored at  70jC. Hybridization,
washing, and detection utilized the same protocols and
probes as for whole-mount analysis. Subsequently, the
slides were counterstained with Nuclear Fast Red (Vector
Laboratories, Burlingame, CA), then dehydrated, cleared,
mounted, and stored at RT. For paraffin sections, animals
were fixed in 4% paraformaldehyde before embedding and
then stained with hematoxylin and eosin. Skeletal staining
of 18.5 dpc embryos, neonates, and adults with alcian blue
and alizarin red was performed as described (Martin et al.,
1995).
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To assess the requirement for AP-2a in NCCs during
mouse development, we conditionally inactivated AP-2a by
utilizing a Cre/loxP recombination system. First, a new line
of mice containing a floxed conditional allele of AP-2a
(Alflox) was generated by a standard gene-targeting strategy
(Fig. 1). In this allele, two loxP sites were placed within
introns so as to flank essential AP-2a coding sequences
within the fifth and sixth exons that are crucial for the
dimerization and DNA binding activities of this transcrip-
tion factor. Mice that were either heterozygous or homozy-
gous for the Alflox allele were viable and fertile, indicating
that the minor genome modifications caused by insertion of
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strain of mice was generated that was heterozygous for both
the established Wnt1-Cre transgene (Danielian et al., 1998)
and the previously generated AP-2a:LacZ knock-in (KI)
allele (Brewer et al., 2002; see Materials and methods). The
Wnt1-Cre transgene enables floxed genes to be targeted
specifically in the neural crest (Brault et al., 2001; Chai et
al., 2000; Danielian et al., 1998; Jiang et al., 2000). The KI
allele is an AP-2a-null allele that expresses lacZ under the
control of the endogenous AP-2a regulatory sequences and
enables cell populations expressing the AP-2a locus to be
readily visualized by h-galactosidase staining (Brewer et al.,
2002). These Wnt1-Cre; +/KI mice were then bred to
homozygous Alflox mice and the offspring examined in
terms of both genotype and phenotype—initially from birth
onwards. Mendelian ratios for all genotypes were observed
postnatally in the newborn pups (Table 2 and data not
shown). This finding was expected because even AP-2a-
null mice survive into the immediate postnatal period
despite their major developmental defects (Schorle et al.,
1996; Zhang et al., 1996). However, when a substantial
number of the pups derived from conditional allele matings
were allowed to progress to weaning (3 weeks of age), there
was a significant reduction in the number of live Wnt1-Cre;
Floxdel/KI mice compared to the other possible genotypes.
Thus, although mutant pups are viable at a low frequency,
the vast majority (approximately 80–90%) either die soon
after birth or fail to thrive before weaning compared with
their littermates.
The specific role of the neural crest in the high rate of
lethality of Wnt1-Cre; Floxdel/KI mice was determined by
examining recombination at the Alflox allele in NCC- and
non-NCC-derived tissues of affected pups. PCR analysis
confirmed that Cre-mediated deletion of the Alflox allele to
the Floxdel allele (Fig. 1A) occurred only in tissues with a
substantial neural crest component including the thyroid,
thymus, and adrenal glands (Fig. 1B). In contrast, we did
not observe recombination in the liver, spleen, or kidney of
the same mice or in control embryos lacking the Wnt1-Cre
transgene (Fig. 1B and data not shown). These results
confirm that Cre recombinase is capable of recombining
loxP sites to delete a critical region of the AP-2a gene in
vivo. Moreover, the findings indicate that the observedTable 2
Postnatal lethality in AP-2a NCC-specific KO
Genotype Floxdel/KI Alflox/KI Floxdel/+ Alflox/+
Phenotype
Cleft secondary palate 17 – – –
Exencephaly 6 2 – –
Failure to thrive 7a – 1 –
Unknown (cannibalized) 4 – – 1
Survive to weaning 5 46 44 43
Total 39 48 45 44
a Died or euthanized between P1 and P4.defects in mice of the appropriate genotype are caused by
neural crest-specific ablation of AP-2a.
Examination of the Wnt1-Cre; Floxdel/KI mice revealed
several reasons for postnatal lethality that could be linked to
defects in neural crest-associated developmental mecha-
nisms. Anencephaly was the most obvious gross morpho-
logical defect and was observed in approximately 15–20%
of the mutant newborn pups. This pathology affected the
midbrain region of the head and led to immediate postnatal
death. Examination of Wnt1-Cre; Floxdel/KI mice at earlier
developmental timepoints revealed a comparable incidence
of embryos with extensive exencephaly affecting the mid-
brain and rostral hindbrain (Figs. 2A, B). Similar cranial
neural tube closure defects are also observed in mice that
are heterozygous for the AP-2a:LacZ KI allele (Table 2 and
data not shown) but at a much lower frequency than for the
NCC-specific knockout mice. Exencephaly is also a hall-
mark of the AP-2a-null mouse (Fig. 2C), but in this
instance the defect is fully penetrant and affects the entire
cranial neural tube (Schorle et al., 1996; Zhang et al.,
1996). Nevertheless, the elevated penetrance of exence-
phaly in the neural crest tissue-specific knockout model
indicates that Wnt1-Cre-mediated deletion of AP-2a at the
margins of the neural tube predisposes the mouse to
exencephaly. This conclusion is reinforced by the occasion-
al Wnt1-Cre; Floxdel/KI embryo we obtained with a
more extensive neural tube defect (NTD) that affects the
entire cranial region—akin to the AP-2a-null phenotype
(W. Feng, unpublished observations). Note that neural tube
closure defects in Wnt1-Cre; Floxdel/KI mice and the AP-
2a-null mice are confined to the cranial neural tube and do
not appear to affect the trunk neural tube.
Anencephalic Wnt1-Cre; Floxdel/KI pups died and were
frequently cannabalized within the first few hours after birth.
A separate class of mice initially had a normal external
appearance in the immediate postnatal period, but then began
to develop respiratory distress and died before P1. This
phenotypic class was the most common and represented
approximately 50% of Wnt1-Cre; Floxdel/KI mutants. The
mutants became progressively more cyanotic before death,
little or no milk could be observed in their stomachs, and
their digestive tracts became bloated with gas. These symp-
toms are frequently indicative of a cleft secondary palate
(CP) and gross morphological examination of the affected
Wnt1-Cre; Floxdel/KI mice indeed revealed this defect
(Figs. 2D, E). In normal mouse development, the paired
palatal shelves begin to arise from the NCC-derived maxil-
lary processes of branchial arch 1 (BA1) at E12.5 (Kaufman
and Bard, 1999; Rossant and Tam, 2002). Subsequently, the
palatal shelves elevate, curve above the dorsum of the
tongue, appose, and fuse to form the roof of the oropharynx
by E16.5 (Kaufman and Bard, 1999; Rossant and Tam,
2002). However, in coronal sections of affected E16.5
Wnt1-Cre; Floxdel/KI embryos, the palatal shelves have
failed to fuse although they have elevated normally (Figs.
2F, G). Moreover, the tongue, which can sometimes interfere
Fig. 2. Exencephaly and cleft secondary palate in the Wnt1-Cre; Floxdel/KI model. (A–C) Lateral views of E12.5 Alflox/KI littermate control (A) and
exencephalic Floxdel/KI mouse heads (B) stained in whole mount for expression of the AP-2a:LacZ KI allele. Panel C shows an E12.5 AP-2a-null KI/KI
mouse head for comparison. (D and E) Ventral view of upper jaws of P1.5 Alflox/KI littermate control (D) and Floxdel/KI mouse with cleft palate (E). The
lower jaw has been displaced to allow photographic access. (F and G) Coronal section of snout of E16.5 Alflox/KI littermate control (F) and Floxdel/KI mouse
with cleft palate (G). In G, the connection between the upper and lower jaws was severed for whole-mount photography before sectioning. The artery
associated with the vomeronasal organ (v) is smaller in the mutant, a phenomenon also apparent in the FNP-specific AP-2a KO model (Nelson and Williams,
2003). i, incisor primordium in lower jaw; ns, nasal septum; ps, palatal shelves; t, tongue; v, vomeronasal organ.
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size and position in the mutants. Less severe defects in fusion
of the secondary palate—partial or incomplete fusions—
were also observed in several of the mice that survived after
P1 but failed to thrive (data not shown). Note that craniofa-
cial defects in the original AP-2a-null mice were too severe
to enable the study of palatal shelf formation (Schorle et al.,
1996; Zhang et al., 1996). The current studies demonstrate
that AP-2a influences formation of the secondary palate and
further indicate that a major consequence of the NCC-
specific disruption of AP-2a is most likely the failure of
apposition of the palatal shelves.Overall, we postulate that defects associated with CP
account for a substantial portion of the lethality observed
between birth and weaning. Nevertheless, it was possible
that other NCC-specific defects might influence viability,
especially given that AP-2a-null mice have many patholo-
gies associated with the neural crest including craniofacial
skeleton defects and heart outflow tract abnormalities
(Brewer et al., 2002; Schorle et al., 1996; Zhang et al.,
1996). Therefore, we examined the function of NCCs in the
Wnt1-Cre; Floxdel/KI mice by performing an analysis of
tissues and organs that had a NCC component. Initially, we
studied the formation, migration, and survival of the NCCs
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into the model. In control embryos that contained this lacZ
allele but lacked Wnt1-Cre, NCCs could be readily visual-
ized using h-galactosidase activity (Figs. 3A, C). Equivalent
staining was observed in the Wnt1-Cre; Floxdel/KI mice
themselves, demonstrating that there was no significant
difference in the formation and migration of the neural crest
in the Wnt1-Cre; Floxdel/KI embryos (Figs. 3B, D). To
extend these findings, we examined the expression of
several other NCC markers. Expression of Sox10 mRNA
in migratory NCCs was comparable between wild-typeFig. 3. Normal NCC migration and PNS formation in the Wnt1-Cre; Floxdel/KI
Alflox/KI littermate controls (A, C, E, G), and Floxdel/KI mice with normal neura
2a:LacZ KI allele (A–D) or Sox10 mRNA (E–H). Note similar staining patterns in
of E10.5 Alflox/KI littermate control (I) and Floxdel/KI mouse (J) stained in whol
and 2, respectively; ov, otic vesicle. (K and L) Lateral view of E10.5 Alflox/KI litte
for neurofilament. Note similar staining patterns in both mice. The cranial nervescontrols and Wnt1-Cre; Floxdel/KI mice from E9.5 to
E10.5 in agreement with the data obtained with the AP-
2a:LacZ KI marker (Figs. 3E–H). We also examined the
expression of Hoxa-2 because this gene contains a critical
AP-2 binding site required for its NCC-specific gene ex-
pression in mouse (Maconochie et al., 1999). The pattern
and levels of Hoxa-2 expression associated with the NCC of
the branchial arches was not noticeably affected in the
Wnt1-Cre; Floxdel/KI model (Figs. 3I, J). This result stands
in contrast to data obtained with zebrafish AP-2a lockjaw
mutation, in which Hoxa-2 expression was noticeablymodel. (A–H) Lateral view of E9.5 (A, B, E, F) and E10.5 (C, D, G, H)
l tube closure (B, D, F, H) stained in whole mount for expression of the AP-
NCC derivatives of all mice. (I and J) Lateral view of branchial arch region
e mount for Hoxa-2 RNA expression. BA1 and BA2 are branchial arches 1
rmate control (K) and Floxdel/KI mouse (L) immunostained in whole mount
, cranial ganglia, and dorsal root ganglia (DRG) are indicated in panel K.
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previous studies performed on the highly dysmorphic AP-
2a-null mouse (Knight et al., 2003; Maconochie et al.,
1999). The discrepancy between mouse and zebrafish pre-
sumably reflects the presence of other AP-2 proteins in
mouse NCCs that compensate for loss of AP-2a, whereas
the zebrafish has a greater reliance on the tcfap2a gene for
efficient Hoxa-2 expression.
Extensive apoptosis was detected in specific tissues
derived from the NCCs in the AP-2a-null mouse. Specifi-
cally, the cranial ganglia, and to a lesser extent the facialFig. 4. Craniofacial defects in the Wnt1-Cre; Floxdel/KI model. (A and B) Latera
littermate control (left) and Floxdel/KI mouse (right) post weaning. Note smaller o
and F) Lateral view of P21 skulls. Note in mutant (F) that snout is shorter and flat
box marks general area of detail shown in panel I. (I and J) Detail of frontonasal
shown in panels I and J are different from those in panels G and H. (K–M) Late
arrowheads mark the caudal limit of the zygomatic process of the maxilla. All skull
G, I, K, Alflox/KI littermate control; B, F, H, J, L, M, Floxdel/KI mouse. f, frontal b
n, nasal bone; p, parietal bone; pm, premaxillary bone; x, interfrontal bone freque
zygomatic process of maxilla; *, zygomatic process of squamosomal bone.complex, contained many apoptotic cells that might indicate
programmed cell death in NCCs once they had reached their
final destination (Schorle et al., 1996; Zhang et al., 1996).
Therefore, we performed a similar analysis of apoptosis on
the Wnt1-Cre; Floxdel/KI mice. However, in this instance,
the NCC-specific ablation of AP-2a did not produce any
increase in apoptosis as compared with wild-type controls
(data not shown). We next performed staining with an
antibody specific for neurofilament to investigate further
the architecture of the peripheral nervous system in the
Wnt1-Cre; Floxdel/KI mice. These experiments again dem-l view of E18.5 skulls. Lateral (C) and frontal (D) appearance of Alflox/KI
verall size of mutant, short broad face, small eyes, and white back paws. (E
ter, and the dentition is misaligned. (G and H) Dorsal view of snout. White
suture and fronto-premaxillary suture. Note that the wild type and mutant
ral view of zygomatic process. Panels are aligned at their rostral edges and
s are stained with alcian blue (cartilage) and alizarin red (bone). Panels A, E,
one; fns, frontonasal suture; fpms, fronto-premaxillary suture; j, jugal bone;
ntly seen in mutants, but also in wild-type strains at lower frequency; zpm,
Fig. 5. Middle ear ossicle defects in the Wnt1-Cre; Floxdel/KI model. (A)
The normal morphology of the malleus, incus, and stapes in an
approximately 2-month-old Alflox/KI littermate control. (B and C)
Abnormal ossicle morphology in Floxdel/KI mice. The arrowhead marks
a groove present on the malleus into which the incus normally fits, the
incudomalleal joint. mm, manubrium of the malleus.
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knockout model were essentially identical to their wild-type
counterparts (Fig. 3K, L)—in contrast to the extensive
hypoplasia observed in the same structures in the AP-2a-
null embryos (Schorle et al., 1996; Zhang et al., 1996).
Next, we performed a gross morphological analysis of
other NCC-derived structures in the Wnt1-Cre; Floxdel/KI
mice. As expected, in the Wnt1-Cre; Floxdel/KI mutants
with exencephaly, there were extensive defects in the skull
associated with the neural tube closure defects. Otherwise,
the NCC-derived mouse skeleton was to a great extent
normal in the Wnt1-Cre; Floxdel/KI mice at birth if they
were not anencephalic (Figs. 4A, B). Moreover, these
studies revealed that the adrenals, enteric nervous system,
thymus, thyroid, and heart outflow tract were present and
appeared normal in the mutants (data not shown). Thus, we
conclude that exencephaly and clefting of the secondary
palate probably accounts for the majority of the death
observed in the Wnt1-Cre; Floxdel/KI mice before weaning.
The survival of a limited number of Wnt1-Cre; Floxdel/
KI mice to weaning allowed us to ascertain that the NCC-
specific disruption of AP-2a led to additional abnormalities
in growth and development. These defects affected the
overall size of the mice, the craniofacial skeleton, the middle
ear ossicles, and the melanocytes. Pups of all genotypes
were similar in size at birth. However, Floxdel/KI mice that
survived until weaning were notably smaller in overall size
in comparison to their littermates. On average, the Wnt1-
Cre; Floxdel/KI weanlings weighed 26% less than their
littermates (Figs. 4C, D). The overall size discrepancy of the
mutants during the postnatal growth period was also ac-
companied by a noticeable difference in craniofacial mor-
phology—a persistent shortening of the snout. This defect
became progressively more severe as the mice aged and
eventually led to defects in skin integrity around the eyes
and face that required euthanasia by approximately 2
months of age (data not shown). The skulls of newborn
and adult mutant mice were examined to ascertain the
underlying cause of the craniofacial defects. As stated
previously, there were no gross differences apparent at
E18.5 and P1 between the skulls of mutant mice and their
littermates (Figs. 4A, B), although much of the craniofacial
skeleton is derived from NCCs. However, the analysis of
skulls at later developmental timepoints revealed defects in
the bones associated with the snout (Figs. 4E–H). At
weaning, the mutant nasal bones were shorter and broader
than the equivalent wild-type structures. The ratio of the
nasal bone length to the parietal bone length was 0.66 for
mutant mice, and 0.91 for wild-type mice. The NCC-
derived frontal bones were also noticeably broader and
shorter in the mutants. Detailed examination revealed that
the frontonasal suture located between the nasal and frontal
bones is abnormal and lacks the degree of interdigitation
observed in the equivalent wild-type sutures (Figs. 4G–J).
In contrast, other sutures of the cranial vault appear normal
(Fig. 4 and data not shown). With respect to the jaws, themaxilla was shorter along the anterior posterior axis in the
mutant, but the mandible was essentially normal in size and
shape. The decrease in growth of the maxilla can be best
seen by examination of the zygomatic process which is
consistently shorter in the Wnt1-Cre; Floxdel/KI mice (Figs.
4K–M). The jugal bones are essentially normal in size and
shape, except at their junction with the zygomatic process of
the squamosomal bone. This latter process has an abnormal
oblong stalked shape, possibly to compensate for the short-
ening of the maxilla. The failure of these aspects of facial
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an abnormally small appearance in the intact head (Figs. 4C,
D). In contrast to the snout and upper jaw, the lower jaw was
essentially normal in the mutants, although there may be
subtle changes in the morphology of the condylar process of
the mandible to compensate for the shortened maxilla (data
not shown). NCC-derived skeletal elements of the neck and
throat, including the hyoid bone and the thyroid and cricoid
cartilages, were also normal in appearance (data not shown).
Examination of the teeth, which are also partly derived from
NCCs, indicated that they were all present and of normal
morphology in mutant mice. However, in contrast to control
animals, the teeth in the upper and lower jaws of Floxdel/KI
animals were misaligned, most likely resulting from the
foreshortening of the face (Figs. 4E, F). We postulate that
the defects in dentition and craniofacial morphology limit
food intake and lead to the observed differences in growth
and weight gain between mutant and wild-type mice.
As well as the defects in growth, we also noted that the
Wnt1-Cre; Floxdel/KI weanlings had a defective Preyer’s
reflex, that is, the mice did not startle when subjected to a
loud noise. Other than this defective startle response, theFig. 6. Melanocyte defects in the Wnt1-Cre; Floxdel/KI model. (A and B) Ventra
littermates are completely black on their bellies and show no white patches. (C) A m
right has a white tip and is from a Wnt1-Cre; Floxdel/KI mouse. The tail on themutant mice appeared to have the same gross locomotory
behavior as their littermates. One component required for
normal hearing and the startle response are the middle ear
ossicles—bones derived from NCCs of the first and second
branchial arches (Mallo, 2001). In normal mice, these
ossicles—the malleus, incus, and stapes—each have a
distinctive morphology (Fig. 5A) and are required to relay
and amplify auditory signals from the external ear to the
inner ear. Dissection of these ossicles from Wnt1-Cre;
Floxdel/KI mutant mice demonstrated that all three of these
bones were malformed (Figs. 5B, C). The malleus and
incus, which are generated from NCC-derived BA1 mesen-
chyme (Mallo, 2001), were misshapen but still recognizable
from their overall morphology. The malleus was narrower
across the base than the equivalent wild-type bone and did
not have a well-defined groove into which the incus
normally fits (Fig. 5, arrowhead). The incus, which normal-
ly has a complex three-dimensional shape with protrusions
that connect it to the other two middle ear bones, was much
flatter in the mutants. The protrusions from the body of the
incus were not as well developed and appeared much
shorter. The stapes, derived from BA2, was the mostl white patch on two piebald weaned Floxdel/KI mice. Note that wild-type
utant with white back paws and a white band on the tail. (D) The tail on the
left is from a wild-type littermate.
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characteristic stirrup shape and is composed of an arch and a
base component. In Wnt1-Cre; Floxdel/KI mice, the stapes
was very hypomorphic and only occurred as a small peg-
shaped bone fragment. Consequently, the absence of the
arch of the stapes precluded a connection to the incus.
Furthermore, in normal development, the base of the stapes
is located within the oval window of the cochlea, part of the
inner ear. In the Floxdel/KI mouse, it was also observed that
the oval window was smaller and underdeveloped most
likely resulting from the absence of the characteristic base of
the stapes (data not shown). Together, the defects in the
middle ear ossicles would be sufficient to severely disrupt
hearing in the Wnt1-Cre; Floxdel/KI mice. This new mouse
model demonstrates that NCC-specific expression of AP-2a
is directly responsible for middle ear morphology, a con-
clusion that was not apparent in the original AP-2a-null
mouse because of the severe dysmorphology of the head
(Schorle et al., 1996; Zhang et al., 1996).
The survival of several mice to weaning in the current
model also revealed AP-2a-associated pigmentation defects
that could not be detected in the AP-2a-null mice because
these did not survive beyond birth. With respect to the
melanocyte defects in the current model, all pups in a litter
had a similar coloration at birth. However, as pigmentation
began to develop, differences were observed between wild
type and Wnt1-Cre; Floxdel/KI mice, noticeable as white
patches of variable sizes on the belly of the mutants (Fig.
6). The lack of pigment was also apparent at other distal
sites, as white bands on the tail, or as white paws. The
inappropriate pigmentation in the mutants indicates a
defect in NCC-derived melanocyte lineages in the absence
of AP-2a.Discussion
The availability of a conditional allele of AP-2a enables
the importance of this transcription factor to be ascertained
in specific tissues by mating with appropriate Cre recombi-
nase transgenic strains. Here, we have examined the func-
tion of AP-2a within the NCC population using a Wnt1-Cre
recombinase transgenic line. The data demonstrate that the
presence of AP-2a within NCCs mediates several aspects of
their development and function. The tissue-specific absence
of AP-2a does not alter neural crest formation, proliferation,
and migration because these processes occur normally as
judged by expression of the AP-2a:LacZ KI allele, Hoxa-2,
and Sox10—results consistent with previous studies per-
formed on AP-2a-null mice (Brewer et al., 2002; Zhang et
al., 1996). Nevertheless, several neural crest-associated
defects do arise in AP-2a conditional knockouts and affect
the neural tube, secondary palate, postnatal facial skeleton,
middle ear ossicles, and melanocytes. The combination of
neural tube closure and craniofacial defects results in the
death of the majority of these mice in the immediatepostnatal period—underscoring a critical requirement for
AP-2a in NCCs.
The most common pathology was defective formation of
the secondary palate. In mammals, the secondary palate
separates the nasal and oral cavities and is required to enable
efficient breathing and feeding. Clefting of the secondary
palate in the current model led to the death of approximately
50% of the embryos between birth and P1 due to respiratory
distress and/or feeding problems. A smaller percentage of
mice had a more limited CP and lived through the imme-
diate postnatal period, but failed to thrive between P1 and
weaning. Defective formation of the secondary palate is a
common occurrence in both mice and humans and is
associated with many genetic factors and/or environmental
insults (Murray, 2002; Spritz, 2001; Wilkie and Morriss-
Kay, 2001). The altered expression of at least 40 genes in
the mouse can lead to CP at variable penetrance, indicating
that this dynamic process is very sensitive to disruptions in a
variety of cellular systems. Of particular relevance to the
Wnt1-Cre; Floxdel/KI model, neural crest defects frequently
result in CP because they can alter the spatial relationship
among facial structures. We hypothesize that the NCC-
specific deletion of AP-2a results in an underdevelopment
or a delay in morphogenesis of the palatal shelves that
interferes with apposition and/or fusion. The altered timing
of such morphogenetic processes could lead to the type of
variability we observe in the current model in which
approximately 50% of the mice have a complete cleft, while
others are normal, and several have an intermediate pheno-
type. Although we favor a defect in the growth and
morphogenesis of the neural crest-derived mesenchyme of
the palatal shelves, it is still possible that AP-2a in NCCs
may act via alternative mechanisms. One possibility is that
the expression of AP-2a in the shelf mesenchyme influen-
ces the behavior of the overlying epithelium, which ulti-
mately mediates fusion. Alternatively, the Wnt1-Cre-
mediated loss of AP-2a in multiple tissues of the developing
head could cause a subtle alteration in the architecture of the
developing craniofacial tissues that precludes normal appo-
sition of the palatal shelves at the appropriate time.
Uncovering the specific mechanism causing CP in the
Wnt1-Cre; Floxdel/KI model is hampered by the incomplete
penetrance of the phenotype—a phenomenon that may have
several causes. One set of possibilities, related to the Wnt1-
Cre transgene, are that the timing, tissue-specific distribu-
tion, and/or mosaicism of Wnt1-Cre expression may lead to
the incomplete deletion of AP-2a activity in the appropriate
tissues at the appropriate time (Bally-Cuif et al., 1995;
Brault et al., 2001). Alternatively, variable penetrance may
reflect that a threshold of AP-2a activity has been
approached leading to a stochastic event. Lastly, the vari-
ability in clefting may result from the mixed mouse strain
background we are using in our experiments. One or more
of these possibilities may also be relevant to the partial
penetrance of exencephaly in the Wnt1-Cre; Floxdel/KI
mice. Exencephaly is the earliest abnormality apparent
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approximately 15% of the mutants. In the mouse, the
process of neural tube closure takes place between E8 and
E9 and involves elevation, apposition, and fusion of the
neural folds (Copp et al., 2003; Francis-West et al., 2003;
Juriloff and Harris, 2000). Initial fusion occurs at four
distinct points along the rostral–caudal axis, termed clo-
sures 1, 2, 3, and 4, and fusion spreads outwards from these
initial positions until the entire neural tube is closed. Three
zones of elevation can be envisioned between the initial
closure points in the cranial region of the neural tube.
Region A encompasses the forebrain, region B the midbrain
and rostral hindbrain, and region C the remainder of the
hindbrain. Previous studies demonstrated that the AP-2a-
null mouse has a fully penetrant cranial neural tube closure
defect encompassing regions A, B, and C (Schorle et al.,
1996; Zhang et al., 1996). In contrast, the neural tube
closure defect caused by the NCC-specific deletion of AP-
2a is most frequently localized to just region B and
produces a type of exencephaly encompassing only the
midbrain and rostral hindbrain. Although it is possible that
the preference for region B reflects activation of Wnt1-Cre
in the midbrain region at the appropriate developmental
time, we favor the explanation that region B is the most
sensitive to the relative levels of AP-2a associated with the
borders of the neural tube. Further more, such a hypothesis
would explain why heterozygous AP-2a mice can also
develop exencephaly limited to region B, but at an even
lower frequency than the Wnt1-Cre; Floxdel/KI model.
Together, the present data reinforce the importance of AP-
2a in neural tube closure and further indicate that AP-2a is
likely required in the NCCs or ectoderm at the neural plate
border for this process to occur normally. The mechanism
by which the Wnt1-Cre-mediated loss of AP-2a in the
NCCs and/or in the neighboring ectodermal cells ultimately
results in NTDs may involve the precise positioning of the
neural plate border. In Xenopus, alterations in the levels of
AP-2a have been shown to impact the neural plate bound-
ary and subsequently neurulation (Luo et al., 2002). A
related alteration in the size of the neural plate in mouse
could impact the complex morphogenetic changes needed
for appropriate elevation and apposition of the neural folds.
A small percentage of Wnt1-Cre; Floxdel/KI mice sur-
vived until weaning, by which time several other patholo-
gies became evident. The first of these was the reduced size
of mutant pups compared with their littermates. This growth
reduction correlates with defects in the postnatal develop-
ment of the craniofacial skeleton, particularly the bones
associated with the snout and orbits. The frontal and nasal
bones were broader and shorter in the mutants, and this
correlated with an altered morphology of the intervening
frontonasal suture that is required for their growth (Mao,
2002; Opperman, 2000). In wild-type mice, this suture
develops a progressively more interdigitated appearance as
the mice age. However, digitation of this suture was greatly
suppressed in the mutants. The appearance of the othercraniofacial sutures was relatively normal, although the
bone fronts or mesenchyme of these structures are partly
NCC-derived (Jiang et al., 2002). This discrepancy may
reflect that the facial sutures overlie the cartilaginous
elements of the facial complex, whereas the cranial vault
sutures are in contact with—and may receive signals from—
the meninges covering the brain (Brault et al., 2001; Jiang et
al., 2002). If the local environment was the sole reason
behind the difference in suture morphology, one might
predict that the digitation patterns of the frontonasal suture
and the frontal-premaxillary suture would be equally affect-
ed. However, the latter suture appears superficially similar
between mutant mice and their littermates. Therefore, we
postulate that the frontonasal suture must be particularly
susceptible to the loss of AP-2a—possibly reflecting the
high AP-2a expression levels that are normally observed in
the NCC-derived mesenchyme of the developing FNP
(Mitchell et al., 1991; Zhang and Williams, 2003). The
most parsimonious explanation for the observed defects in
facial growth after birth is that the loss of AP-2a has
affected the function of the sutures, which are sites of AP-
2a expression in the postnatal period (Nelson and Williams,
2003). Nevertheless, we cannot exclude the possibility that
the defects in facial outgrowth might be caused by subtle
alterations in the shape and/or function of the craniofacial
skeleton during embryogenesis that are only manifested
after birth. Ultimately, temporal-specific removal of AP-
2a at different stages of facial growth and development will
be needed to resolve these issues.
The altered morphology of the zygomatic process,
caused by changes in the size and shape of the maxilla
and squamosmal bones, restricts the size of the orbit and
presumably gives rise to the persistent problems associated
with the eye and its surrounding skin. The defects in the
body of the maxilla may be in response to the reduction in
size of the overlying nasal and frontal bones. Alternatively,
defects in the overall size of the maxilla may be a direct
consequence of the loss of AP-2a in the NCCs of the
maxillary process. This latter possibility is also supported
by the observation that the Wnt1-Cre; Floxdel/KI mice have
a high incidence of CP because the palatal shelves also
originate from the mesenchyme of the NCC-derived max-
illary process. Similarly, the alteration in the shape of the
squamosomal bone may be in response to defects in the
maxilla, or be a direct effect of the absence of AP-2a in the
NCC BA1 mesenchyme from which it is derived. Resolu-
tion of whether defects in the derivatives of the squamoso-
mal, maxillary, and FNPs are independent or linked events
will require new strains of Cre recombinase transgenic mice
specific for subsets of the neural crest and its derivatives. In
this context, we have recently developed a new strain of
mouse that expresses Cre recombinase specifically in the
FNP and not in other NCC derivatives (Nelson and Wil-
liams, 2003). When combined with the floxed AP-2a allele,
this model does not cause CP or major orbit defects, but
does lead to shortening of the snout in the postnatal period
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two studies demonstrate that the elimination of AP-2a in the
entire cranial NCC causes a more severe phenotype than
loss in the FNP alone. Furthermore, the data indicate that the
FNP defects in the Wnt1-Cre; Floxdel/KI model are inde-
pendent of the maxillary and squamosomal defects. The
normal viability observed in FNP model makes these mice
more suitable for studies of the frontonasal suture than the
Wnt1-Cre; Floxdel/KI strain in which only a low percentage
of affected mice survive until weaning.
Together, the combined changes in the craniofacial
skeleton of the Wnt1-Cre; Floxdel/KI mice result in the
short snout, hypertelorism, tooth misalignment, and eye
socket defects observed in the intact face. Interestingly,
the human AP-2a gene, TFAP2A, maps to chromosome
6p24 in a region associated with the 6p deletion syndrome
(Davies et al., 1995, 1999; Topping et al., 2002; Warren et
al., 1996). The deletions in this syndrome affect only one
copy of chromosome 6, and are variable in their position
and extent. Consistent with the variability in 6p alterations,
the resulting congenital defects themselves are quite diverse
but they frequently include facial clefting, hypertelorism,
flat face, and suture abnormalities, as well as body wall, eye,
genitalia, and heart problems (Davies et al., 1995, 1999;
Law et al., 1998; Topping et al., 2002). This spectrum of
human pathology shows remarkable overlap with those
caused by the aberrant expression of the mouse AP-2a gene
(this report and Brewer et al., 2002; Hilger-Eversheim et al.,
2000; Nelson and Williams, 2003). Therefore, haploinsuffi-
ciency of the TFAP2A gene may be a significant contribu-
tory factor in many cases of 6p deletion syndrome.
The defects in dentition and craniofacial morphology in
the viable mutant mice undoubtedly limit their food intake
and lead to a reduced growth potential. Most other NCC-
derived organs and tissues that would control physiology,
metabolism, and food intake such as the heart outflow tract,
PNS, enteric nervous system, adrenal and/or thyroid glands
appeared morphologically normal in the mutants. It is still
possible that the loss of AP-2a led to subtle changes in
shape and/or function that could impact growth regulation in
concert with the craniofacial defects. Nevertheless, the
observation that viable Wnt1-Cre; Floxdel/KI mice are
otherwise almost normal in appearance and behavior strong-
ly suggests that there was not a catastrophic failure of
hormone-regulated metabolic function or nervous system
regulation in the absence of AP-2a in the neural crest.
The one behavioral defect we did detect in the Wnt1-Cre;
Floxdel/KI model was an absence of Preyer’s reflex—a
simple measure of hearing potential. Examination of the
three middle ear ossicles revealed that they were all mis-
shapen and the inability of these malformed structures to
interact appropriately is the likely cause of conductive
hearing loss in the mutant mice. We further note that
melanocyte defects can be associated with hearing loss
because these NCCs contribute to the stria vascularis of
the cochlea (Bennett and Lamoreux, 2003; Steel and Bark-way, 1989)—a structure needed to maintain the electrolyte
balance required for sensory cell function within the inner
ear. Therefore, because the loss of AP-2a also affects
melanocyte development, it is possible that in addition to
the conductive hearing defects, there are also sensoneural
defects that contribute to the hearing loss in the current
model. Indeed, both conductive and progressive sensoneural
hearing loss have been associated with deletion of one
TFAP2A allele in 6p deletion syndrome (Davies et al.,
1999; Law et al., 1998). Thus, further studies will be needed
to ascertain if AP-2a affects the function of the inner ear in
addition to its role in middle ear morphology. These studies
are not possible with the current Wnt1-Cre; Floxdel/KI
model because they have a reduced ability to survive
the stress of anesthesia needed for auditory nerve record-
ings, presumably because of their limited growth status
(T. Williams, unpublished data).
It is possible that the defects in the malleus, incus, and
stapes do not result directly from the loss of AP-2a in their
anlagen but instead reflects that the smaller size of the head
in the mutants restricts growth and morphogenesis of these
ossicles. Two independent observations argue against this
latter possibility and strengthen the link among AP-2a, the
middle ear, and deafness. First, a recent ENU-induced
mutagenesis screen generated a novel mouse strain Doarad
(Dor) with limited hearing potential (Ahituv et al., submitted
for publication). Mapping analysis indicated that the phe-
notype was caused by a point mutation in the AP-2a
activation domain. The malleus, incus, and stapes of these
Dor mice were deformed, although to a much lesser extent
than the Wnt1-Cre; Floxdel/KI model, indicating that de-
velopment of these middle ear ossicles is very sensitive to
the level of active AP-2a. The second line of evidence
comes from two independent zebrafish mutations, lockjaw
and montblanc, which are caused by null mutations in the
homolog of AP-2a (Holzschuh et al., 2003; Knight et al.,
2003). These zebrafish mutants are characterized by loss of
the hyosymplectic cartilage and a reduction of the cera-
tohyal cartilage, both derived from BA2 (Knight et al.,
2003; Schilling, 1997). The zebrafish hyosymplectic carti-
lage is the teleost homolog of the mammalian stapes—
indicating that loss of AP-2a affects the same skeletal
element in these two disparate species. Mutations in several
mouse homeobox genes, including Dlx-1, Dlx-2, and Hoxa-
2, also cause defects in the stapes (Gendron-Maguire et al.,
1993; Mallo, 2001; Ohnemus et al., 2001; Qiu et al., 1995,
1997; Rijli et al., 1993). Overall, though, the NCC-specific
knockout of AP-2a produces a distinct set of abnormalities
for the middle ear ossicles compared with these other
mutants. In contrast to the defects in the stapes, we did
not see major alterations in the other skeletal derivatives of
BA2 and BA3 in the Wnt1-Cre; Floxdel/KI model. These
structures include the styloid process, the greater and lesser
horns of the hyoid, and the body of the hyoid. This stands in
contrast to the zebrafish mutants, in which the BA2-derived
ceratohyal cartilage is also affected (Knight et al., 2003).
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mediated deletion of AP-2a results in defects in the deriv-
atives of the FNP (the nasal and frontal bones), BA1 (CP,
maxilla, squamosomal bones, malleus, incus), and the dorsal
part of BA2 (stapes).
The defects in the melanocyte lineages seen in the Wnt1-
Cre; Floxdel/KI model were not previously noted in the AP-
2a-null mouse models because they die before pigmentation
becomes apparent (Schorle et al., 1996; Zhang et al., 1996).
Therefore, this is the first report of AP-2a-associated
melanocyte defects in the mouse. The inconsistent pigmen-
tation typified by white spotting, white feet, and white tail
tip seen in the current model are presumed to arise by a
reduction in the number of melanoblast stem cells or in the
migratory potential of melanocytes (Bennett and Lamoreux,
2003; Spritz et al., 2003). Mutations in several other mouse
and human genes also generate such piebaldism (Spritz et
al., 2003). One class of these mutations, associated with the
pax3, sox10, endothelin 3, and the endothelin-B receptor
genes, cause defects in both melanocytes and the NCC-
derived enteric nervous system (ENS), leading to both white
spotting and megacolon (Bennett and Lamoreux, 2003). In
contrast, AP-2a resides in the same category as c-kit and
Mitf mutations that affect pigmentation, but do not cause
ENS-associated defects.
Melanocyte populations are very sensitive to the levels
of active c-kit. Homozygous null c-kit mutations cause a
complete absence of skin melanocytes, whereas loss of only
one copy leads to white spots on the belly, feet, tail, and
head. Therefore, the observation that AP-2a- and c-kit-
associated melanocyte defects are similar is intriguing given
that AP-2a can activate c-kit expression in vitro (Bar-Eli,
2001; Nyormoi and Bar-Eli, 2003). Analysis of human
melanoma samples has also shown a significant correlation
between the expression of c-kit and AP-2a in vivo (Bar-Eli,
2001; Nyormoi and Bar-Eli, 2003). The NCC-specific loss
of AP-2a might lead to a substantial reduction in expres-
sion of its potential target c-kit, thus leading to piebaldism.
Alternatively, the function of AP-2a might be more com-
plex and involve the expression of other genes such as Mitf
in the melanocytes, especially because AP-2a and Mitf are
both associated with another disorder—microphthalmia
(Nottoli et al., 1998; West-Mays et al., 1999; Widlund
and Fisher, 2003). Several reports have linked AP-2a
expression with the tumorigenic potential of human mela-
nomas (Bar-Eli, 2001; Nyormoi and Bar-Eli, 2003). Spe-
cifically, loss of AP-2a correlates with an increase in the
metastatic potential of melanoma cells, while the ectopic
expression of AP-2a can reduce metastasis. Our current
findings that the loss of AP-2a can influence melanocyte
formation and/or migration is in agreement with an impor-
tant role for this transcription factor in melanocyte biology.
It would be very useful to determine if the AP-2a-deficient
melanocytes generated in the present study were predis-
posed to melanoma formation. However, it is not possible
to examine whether there is an increased incidence of lateonset neurocristopathies in the current model due to their
short life span.
The Wnt1-Cre-mediated loss of AP-2a in the neural crest
clearly has important consequences for development and
viability, yet the range and severity of the morphological
abnormalities are considerably less than might have been
predicted from the phenotype of the AP-2a knockout mouse
(Brewer et al., 2002; Schorle et al., 1996; Zhang et al.,
1996). There are several explanations that could account for
this unexpected result. One possibility is that the combina-
tion of the Wnt1-Cre and Alflox alleles cannot effectively
remove AP-2a from the neural crest. We do not favor this
explanation because we observe specific recombination of
AP-2a in NCC-derived structures, and previous studies
have shown that both the Wnt1-Cre transgene and the
Alflox allele function effectively in other systems (Brault
et al., 2001; Chai et al., 2000; Danielian et al., 1998; Jiang et
al., 2000, 2002; Nelson and Williams, 2003). A related
possibility is that Wnt1-Cre does not target all NCCs and
that there is a subset that can still express AP-2a or that
sufficient AP-2a is produced before Wnt1-Cre is efficiently
activated to enable major aspects of NCC formation and
function. To address these concerns, we have used the
conditional AP-2a allele in combination with a second
NCC-specific Cre recombinase, P0-Cre (Yamauchi et al.,
1999). This latter Cre recombinase did not produce any
additional AP-2a NCC-specific phenotypes (data not
shown).
Currently, five AP-2 genes have been described in the
mouse and human genomes, and neural crest expression
profiles similar to AP-2a have been described for the related
AP-2h and AP-2g proteins (Cheng et al., 2002; Feng and
Williams, 2003; Hilger-Eversheim et al., 2000; Zhao et al.,
2001). Therefore, one distinct possibility is that these three
mouse AP-2 genes have many redundant functions with
respect to NCC development. Preliminary data indicate that
the AP-2a and AP-2h genes can act in concert in some non-
neural crest derived tissue (T. Williams, unpublished data),
and so we would predict that the combined loss of AP-2a,
AP-2h, and AP-2g are likely to have even more profound
effects on NCC function than the loss of AP-2a alone.
Nevertheless, the potential redundancy of the AP-2 genes
within the neural crest cannot explain the phenotypic differ-
ences between the AP-2a-null mouse and the new Wnt1-
Cre; Floxdel/KI mouse model. Therefore, we strongly favor
the hypothesis that AP-2a is required in tissues other than
the neural crest for major aspects of craniofacial patterning,
cranial ganglia development, and heart outflow tract mor-
phogenesis. Recent studies have demonstrated that, in
addition to NCCs, many tissues within the developing head
are critical for appropriate craniofacial patterning including
the endoderm, mesoderm, ectoderm, and brain (David et al.,
2002; Francis-West et al., 2003; Golden et al., 1999; Hu et
al., 2003; Trainor and Krumlauf, 2000). As outlined below,
we postulate that the second critical site of AP-2a expres-
sion is the ectoderm—a tissue in which significant levels of
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al., 2002; Byrne et al., 1994; Hilger-Eversheim et al., 2000;
Mitchell et al., 1991).
The data obtained from the NCC-specific knockout of
mouse AP-2a can be compared with the recent studies of
this transcription factor in zebrafish and Xenopus. Zebrafish
with AP-2a-null mutations are characterized by fewer
melanocytes, the absence of the enteric nervous system, a
reduction in the size of the cranial ganglia, and hypoplastic
development of the cartilages of the second/hyoid arch. The
defects in the melanocyte lineages and the second arch
derivatives are very similar to those observed with the
Wnt1-Cre-mediated deletion of mouse AP-2a. Moreover,
transplantation studies in zebrafish indicate that AP-2a is
required cell autonomously in the neural crest for develop-
ment of at least the second arch (Knight et al., 2003).
Together, these data demonstrate a critical and conserved
role for the AP-2a gene in patterning this NCC population
between mammals and fish. The observation that signifi-
cant NCC formation still occurs in mice lacking AP-2a
contrasts sharply with recent data obtained in Xenopus
where blocking AP-2a expression or function inhibited
neural crest formation (Luo et al., 2003). These discrep-
ancies may be caused by the different technical approaches
used in the amphibian versus mouse developmental system.
Alternatively, the utilization of AP-2a as a developmental
signal may have altered during certain aspects of vertebrate
evolution.
Data from the current mouse study—combined with the
analysis of Xenopus and zebrafish developmental systems—
reinforce the hypothesis that the AP-2a gene has a critical
role in controlling NCC biology and craniofacial develop-
ment in vertebrates. However, the data obtained with the
Wnt1-Cre; Floxdel/KI model indicate that the direct action
of this transcription factor in the NCCs does not comprise
the only role for AP-2a in craniofacial development. In-
deed, it is now apparent that the role of tcfap2a in mam-
malian face formation is not a straightforward, one time, one
tissue event but that instead AP-2a is required in multiple
tissues and influences craniofacial growth and development
during both prenatal and postnatal life. We postulate that the
ectoderm acts as a second critical site of AP-2a expression
in the mouse, and it is from here that it regulates major
aspects of NCC involvement in the embryonic patterning of
the craniofacial skeleton via control of cell–cell signaling.
This hypothesis is supported by studies of AP-2 expression
in the cephalochordate Amphioxus, in which there is only a
single AP-2 gene (Meulemans and Bronner-Fraser, 2002).
Amphioxus is a primitive chordate, and represents a lineage
that separated from vertebrates before the appearance of
NCCs and their derivatives—including the jaws—during
evolution. Despite the absence of the neural crest in Am-
phioxus, the expression of AP-2 is still present and occurs
chiefly within the non-neural ectoderm. Thus, AP-2 expres-
sion in the ectoderm is an ancestral feature that predates
evolution of the neural crest. In support of a continuing rolefor AP-2a in the ectoderm of vertebrates, studies in Xenopus
indicate that altering expression of AP-2a in ectoderm can
disrupt morphogenesis (Luo et al., 2002). Moreover, recent
data obtained from the mouse strongly suggest that expres-
sion of AP-2a in the ectoderm is critical for a different
developmental pathway—body wall closure (Brewer and
Williams, in press). In conclusion, the expression of AP-2a
in mouse NCCs regulates multiple aspects of development
and is particularly important for sculpting the morphology
of the skeletal components within the face and ear. Alter-
ations in the function or regulation of genes such as AP-2a
might represent an important mechanism for driving mor-
phological changes in facial architecture among related
species during evolution.Acknowledgments
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